Within this landscape, tirzepatide stands out because of its dual GIP/GLP-1 mechanism, which produces superior weight loss compared to GLP-1-only medications
However, its not approved for use as a weight loss medication, so your insurance may not cover the costs for this use
and end-systolic pressure-volume relationship, ESPVR
Jiang L, Wang J, Wang K, Wang H, Wu Q, Yang C, et al
The authors noted, ...semaglutide was superior to placebo for MACE reduction at all levels of baseline weight or waist circumference from early in the study. Here is a gift link to a New York Times article about this study
Ros comprehensive weight loss program offers ongoing support that helps patients stay consistent, lose weight, and feel more like themselves again as evidenced by these semaglutide before and after stories